• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALCON LABORATORIES IRELAND LTD. CLAREON VIVITY TORIC EXTENDED VISION UV ABSORBING IOL; LENS, INTRAOCULAR, TORIC OPTICS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALCON LABORATORIES IRELAND LTD. CLAREON VIVITY TORIC EXTENDED VISION UV ABSORBING IOL; LENS, INTRAOCULAR, TORIC OPTICS Back to Search Results
Model Number CCWET5
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Blurred Vision (2137)
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Investigation including root cause analysis is in progress.A supplemental mdr will be filed as necessary in accordance with 21 cfr 803.56 when additional reportable information becomes available.The manufacturer internal reference number is: (b)(4).
 
Event or Problem Description
A non healthcare professional reported that, after intraocular lens implantation surgery, the patient having issues with the vision.Hence the lens was explanted and replaced with another lens in a secondary procedure.The clinical reason for explant was patient vision issues.
 
Additional Manufacturer Narrative
The product was returned for analysis.Intra ocular lens (iol) returned in 3 segments in an non-company sealed pouch.Both iol segments attached to pouch with labels.Solution is dried on the iol.One haptic is broken/torn and is returned, the other haptic is intact.The optic is torn/split-cut dividing the iol in two and scratched/marked-rejectable.No other observations.The reporter stated that the "clinical reason for explant is patient did not like vision".The file shows the lens model 5.185 toric iol was replaced with a lens model 5.185 toric iol.The root cause for the reported complaint could not be determined.The exchange to a company model lens, may suggest that the replacement lens model was an improved choice for the patient's vision needs.Based on the results from the product history record, the products met release criteria.The manufacturer internal reference number is: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CLAREON VIVITY TORIC EXTENDED VISION UV ABSORBING IOL
Common Device Name
LENS, INTRAOCULAR, TORIC OPTICS
Manufacturer (Section D)
ALCON LABORATORIES IRELAND LTD.
cork business&technology park
model farm road
cork 00000
EI  00000
Manufacturer (Section G)
ALCON LABORATORIES IRELAND LTD.
cork business&technology park
model farm road
cork 00000
EI   00000
Manufacturer Contact
jonathan schlech
6201 south freeway
mail stop ab2-6
fort worth, TX 76134
8007579780
MDR Report Key18835870
Report Number9612169-2024-00190
Device Sequence Number15260643
Product Code MJP
UDI-Device Identifier00380652455978
UDI-Public00380652455978
Combination Product (Y/N)N
Initial Reporter StateOH
Initial Reporter CountryUS
PMA/510(K) Number
P190018
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2023
Device Explanted Year2024
Reporter Type Manufacturer
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date (Section B) 05/31/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date03/26/2025
Device Model NumberCCWET5
Device Catalogue NumberCCWET5.185
Device Lot Number25298431
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/01/2024
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 02/08/2024
Supplement Date Received by Manufacturer05/03/2024
Initial Report FDA Received Date03/05/2024
Supplement Report FDA Received Date05/31/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured11/02/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
DISCOVISC; MONARCH III CARTRIDGE D; MONARCH III INJECTOR; ORA SYSTEM WITH VERIFEYE MESSAGING
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-